Ana
Fernández Montes
Hospital Son Llàtzer
Palma, EspañaPublicacións en colaboración con investigadores/as de Hospital Son Llàtzer (4)
2024
-
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain
Clinical and Translational Oncology, Vol. 26, Núm. 4, pp. 864-871
2023
-
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 4077-4089
-
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
Therapeutic Advances in Medical Oncology, Vol. 15
2020
-
Metastatic colorectal cancer. First line therapy for unresectable disease
Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-10